Answers are grounded in this paper and cite their sources.
Chronic endometritis (CE) is a persistent inflammatory disorder of the endometrium that has been associated with impaired endometrial receptivity and implantation failure. The role of antibiotic therapy has been debated with treatment responses variable. This study aimed to identify factors associated with persistence of CE at follow-up biopsy in a large real-world cohort. Clinical data of patients diagnosed with CE were extracted from the Clinical Data Analysis and Reporting System (CDARS) of the Hong Kong Hospital Authority between January 2000 and December 2024. Patients with histopathologically confirmed CE with follow-up endometrial biopsy were included. Consecutive pathology records within 14 days were collapsed into a single episode; the first and second episodes were designated TP1 and TP2, and only patients with a TP2 episode at least 14 days after TP1 were analyzed. The primary outcome was persistence of CE at TP2. Of 14,988 patients with pathologically confirmed CE, 3,119 had matched follow-up. The overall resolution rate was 79.8% (2,490/3,119). Univariable analysis showed higher odds of persistence with penicillin/beta-lactamase inhibitor (OR 1.41, 95% CI 1.06–1.86, p = 0.016), narrow-spectrum penicillins (OR 1.88, 95% CI 1.09–3.13, p = 0.019) and fluoroquinolones (OR 2.48, 95% CI 1.20–4.92, p = 0.011). After multivariable adjustment, no antibiotic class was significantly associated with treatment outcome. Age was the only factor independently associated with persistence. Compared with the reference group (25–44 years), patients aged 45–59 years had significantly lower odds of persistence (aOR 0.77; 95% CI 0.64–0.93; p = 0.007), whereas those aged ≥ 75 years had higher odds (aOR 2.29; 95% CI, 1.52–3.43; p < 0.001). The ≤ 24-year and 60–74-year groups did not differ significantly from the reference (aOR 0.94, 95% CI 0.14–3.80 and aOR 1.06, 95% CI 0.57–1.86, respectively). Baseline and change in neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), or systemic immune-inflammation index (SII) were insignificant (p>0.05). Persistence of CE was associated with age in a non-linear pattern, with lower odds in women aged 45–59 years and higher odds in those aged ≥ 75 years relative to the 25–44-year reference. Antibiotic class is not associated with treatment outcomes, and blood-based inflammatory markers were not associated with treatment response; current data provide insufficient evidence to support their use for routine treatment monitoring. Due to poor model discrimination, age identifies a population at higher risk rather than a usable individual predictor. These findings support further study of age-related persistence but do not support age-based treatment decisions.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: